151 related articles for article (PubMed ID: 1807447)
1. Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites.
Brady JF; Ishizaki H; Fukuto JM; Lin MC; Fadel A; Gapac JM; Yang CS
Chem Res Toxicol; 1991; 4(6):642-7. PubMed ID: 1807447
[TBL] [Abstract][Full Text] [Related]
2. Modulation of rat hepatic microsomal monooxygenase enzymes and cytotoxicity by diallyl sulfide.
Brady JF; Wang MH; Hong JY; Xiao F; Li Y; Yoo JS; Ning SM; Lee MJ; Fukuto JM; Gapac JM
Toxicol Appl Pharmacol; 1991 Apr; 108(2):342-54. PubMed ID: 2017758
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of the chemoprotective agent diallyl sulfide to glutathione conjugates in rats.
Jin L; Baillie TA
Chem Res Toxicol; 1997 Mar; 10(3):318-27. PubMed ID: 9084912
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of diallyl sulfone against acetaminophen-induced hepatotoxicity in mice.
Lin MC; Wang EJ; Patten C; Lee MJ; Xiao F; Reuhl KR; Yang CS
J Biochem Toxicol; 1996; 11(1):11-20. PubMed ID: 8806047
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cytochrome P450 2B1/2 genes by diallyl sulfone, disulfiram, and other organosulfur compounds in primary cultures of rat hepatocytes.
Pan J; Hong JY; Li D; Schuetz EG; Guzelian PS; Huang W; Yang CS
Biochem Pharmacol; 1993 Jun; 45(11):2323-9. PubMed ID: 8390837
[TBL] [Abstract][Full Text] [Related]
6. Relationship between cytochrome P450 2E1 and acetone catabolism in rats as studied with diallyl sulfide as an inhibitor.
Chen L; Lee M; Hong JY; Huang W; Wang E; Yang CS
Biochem Pharmacol; 1994 Dec; 48(12):2199-205. PubMed ID: 7811301
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by allyl sulfides and phenethyl isothiocyanate of methyl-n-pentylnitrosamine depentylation by rat esophageal microsomes, human and rat CYP2E1, and Rat CYP2A3.
Morris CR; Chen SC; Zhou L; Schopfer LM; Ding X; Mirvish SS
Nutr Cancer; 2004; 48(1):54-63. PubMed ID: 15203378
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide (DAS) and related compounds from garlic.
Yang CS; Chhabra SK; Hong JY; Smith TJ
J Nutr; 2001 Mar; 131(3s):1041S-5S. PubMed ID: 11238812
[TBL] [Abstract][Full Text] [Related]
9. Protection from 1,1-dichloroethylene-induced Clara cell injury by diallyl sulfone, a derivative of garlic.
Forkert PG; Lee RP; Dowsley TF; Hong JY; Ulreich JB
J Pharmacol Exp Ther; 1996 Jun; 277(3):1665-71. PubMed ID: 8667236
[TBL] [Abstract][Full Text] [Related]
10. Formation of N-alkylprotoporphyrin IX from metabolism of diallyl sulfone in lung and liver.
Black GP; Collins KS; Blacquiere DP; Forkert PG
Drug Metab Dispos; 2006 Jun; 34(6):895-900. PubMed ID: 16510538
[TBL] [Abstract][Full Text] [Related]
11. Modulation of rat hepatic cytochrome P-450 activity by garlic organosulfur compounds.
Reicks MM; Crankshaw DL
Nutr Cancer; 1996; 25(3):241-8. PubMed ID: 8771567
[TBL] [Abstract][Full Text] [Related]
12. Decrease of hepatic catalase level by treatment with diallyl sulfide and garlic homogenates in rats and mice.
Chen L; Hong JY; So E; Hussin AH; Cheng WF; Yang CS
J Biochem Mol Toxicol; 1999; 13(3-4):127-34. PubMed ID: 10098897
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of hepatic CYP2E1 by an epoxide of diallyl sulfone.
Premdas PD; Bowers RJ; Forkert PG
J Pharmacol Exp Ther; 2000 Jun; 293(3):1112-20. PubMed ID: 10869417
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional activation of cytochrome P450 2B1/2 genes in rat liver by diallyl sulfide, a compound derived from garlic.
Pan J; Hong JY; Ma BL; Ning SM; Paranawithana SR; Yang CS
Arch Biochem Biophys; 1993 May; 302(2):337-42. PubMed ID: 8489239
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of garlic oil and its three major organosulfur components on the hepatic detoxification system in rats.
Wu CC; Sheen LY; Chen HW; Kuo WW; Tsai SJ; Lii CK
J Agric Food Chem; 2002 Jan; 50(2):378-83. PubMed ID: 11782211
[TBL] [Abstract][Full Text] [Related]
16. The garlic ingredient diallyl sulfide inhibits cytochrome P450 2E1 dependent bioactivation of acrylamide to glycidamide.
Taubert D; Glöckner R; Müller D; Schömig E
Toxicol Lett; 2006 Jun; 164(1):1-5. PubMed ID: 16337756
[TBL] [Abstract][Full Text] [Related]
17. Screening of organosulfur compounds as inhibitors of human CYP2A6.
Fujita K; Kamataki T
Drug Metab Dispos; 2001 Jul; 29(7):983-9. PubMed ID: 11408364
[TBL] [Abstract][Full Text] [Related]
18. Modification of hepatic drug-metabolizing enzymes in rats treated with alkyl sulfides.
Siess MH; Le Bon AM; Canivenc-Lavier MC; Suschetet M
Cancer Lett; 1997 Dec; 120(2):195-201. PubMed ID: 9461037
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of cytochrome P450 2E1 by tert-butylisothiocyanate.
Kent UM; Roberts ES; Chun J; Hodge K; Juncaj J; Hollenberg PF
Chem Res Toxicol; 1998 Oct; 11(10):1154-61. PubMed ID: 9778311
[TBL] [Abstract][Full Text] [Related]
20. Effect of diallyl sulfide on rat liver microsomal nitrosamine metabolism and other monooxygenase activities.
Brady JF; Li DC; Ishizaki H; Yang CS
Cancer Res; 1988 Nov; 48(21):5937-40. PubMed ID: 3167846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]